期刊文献+

海洋抗肿瘤环酯肽的研究进展 被引量:1

Research Development of Antitumoral Cyclodepsipeptides from Marine Resources
下载PDF
导出
摘要 对来自海洋微生物、海绵动物、软体动物、尾索动物中的抗肿瘤环酯肽的研究进展进行了综述,并对该领域未来的研究重点进行了展望。 The latest research advances on antitumoral cyclodepsipeptides from marine microorganisms,sponges,mollusks and ascidians were reviewed in this paper,and the main prospects in this field for further research in the future were proposed.
出处 《化学与生物工程》 CAS 2011年第5期1-6,共6页 Chemistry & Bioengineering
基金 国家自然科学基金资助项目(20672086 20802057) 国家人事部回国留学人员科技基金资助项目(国人厅发[2007]170号) 西北工业大学基础科研基金资助项目(JC200824) 西北工业大学研究生创业种子基金资助项目(Z2010027)
关键词 环酯肽 抗肿瘤活性 海洋药物 海洋资源 天然产物 cyclodepsipeptide antitumoral activity marine drug marine resource natural product
  • 相关文献

参考文献31

  • 1Luesch H,Yoshida W Y,Moore R E,et al.Total structure determination of apratoxin A,a potent novel cytotoxin from the marine cyanobacterium Lyngbya majuscuLa[J].Am Chem Soc,2001,123 (23):5418-5423. 被引量:1
  • 2Ma D W,Zou B,Cai G R,et al.Total synthesis of the cyclodepsipeptide apratoxin A and its analogues and assessment of their biological activities[J].Chem Eur,2006,12(29):7615-7626. 被引量:1
  • 3Shen S S,Zhang P T,Lovchik M A,et al.Cyclodepsipeptide toxin promotes the degradation of Hsp90 client proteins through chaperone-mediated autophagy[J].J Cell Biol,2009,185(4):629-639. 被引量:1
  • 4Luesch H,Yoshida W,Moore R,et al.New apratoxins of marine cyanobacterial origin from guam and palau[J].Bioorg Med Chem,2002,10(6):1973-1978. 被引量:1
  • 5Sugiyama H,Watanabe A,Teruya T,et al.Synthesis of palau'amide and its diastereomers:Confirmation of its stereostructure[J].Tetrahedron Lett,2009,50(52):7343-7345. 被引量:1
  • 6Xie W Q,Zou B,Pei D Q,et al.Total synthesis of cyclic tetrapeptide FR235222,a potent immunosuppressant that inhibits mammalian histone deacetylases[J].Org Lett.2005,7(13):2775-2777. 被引量:1
  • 7Matthew S,Ross C,Rocca J R,et al.Lyngbyastatin 4,a dolastatin 13 analogue with elastase and chymotrypsin inhibitory activity from the marine cyanobacterium Lyngbya confervoides[J].J Nat Prod,2007,70(1):124-127. 被引量:1
  • 8Matthew S,Paul V J,Luesch H.Tiglicamides A~C,cyclodepsipeptides from the marine cyanobacterium Lyngbya confervoides[J].Phytochemistry,2009,70(17-18):2058-2063. 被引量:1
  • 9Matthew S,Ross C,Paul V J,et al.Pompanopeptins A and B,new cyclic peptides from the marine cyanobactenum Lyngbya confervoides[J].Tetrahedron,2008,64(18):4081-4089. 被引量:1
  • 10Liu L,Rein K S.New peptides isolated from Lyngbya species:A review[J].Mar Drugs,2010,8(6):1817-1837. 被引量:1

二级参考文献72

  • 1孙雪文,邓洪渊,谭红.环肽的分析方法与研究[J].世界科技研究与发展,2005,27(4):72-78. 被引量:7
  • 2Verschraegen CF, Glover K. ET-743 (PharmaMar/NCI/Ortho Biotech) [J]. Curt Opin InvestinK DruKs, 2001, 2(11):1631. 被引量:1
  • 3Scotto KW. ET-743~ More than an innovative machanism of action[J]. Anticancer Drugs, 2002, 13 suppl 1 :S3. 被引量:1
  • 4Cvetkovic RS, Figgitt DP, Plosker GL. ET-743 [J].Drugs,2002,62(8) .- 1185. 被引量:1
  • 5Gajate CA. Mollinedo F. Differential cytostatic and apoptotic effects of ecteinascidin-743 in cancer cells. Transcriptiondependent cell cycle arrest and transcrlption-independent JNK and mitochondrial mediated apoptosis[J]. J Biol them, 2002,277(44) : 41580. 被引量:1
  • 6Michael V. Chemist Improves Synthesis of Scarce Drugs[R]. NIH Record, 2000. 被引量:1
  • 7Shengkan J, Barbara G, Glynn F, et al. Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation[J]. Proc Natl Acad Sci USA, 2000,97 (12) :6775. 被引量:1
  • 8Kesteren C, Cvitkovic E, Taarnma A, eta1. Pharmacokinetics and pharmacodynamics of the novel marine-derived anticancer agent ecteinaseidin 743 in a phase I dose-finding study[J]. Clin Cancer Res, 2000,6(12) :4725. 被引量:1
  • 9Taamma A, Misset JL, Riofrio M, ee al. Phase I and pharmacokinetic study of ecteinascidin-743, a new marine compound, administered as a 24-hour continuous infusion in patients with solid tumors[J]. J Clin Oncol, 2001,19(5) :1256. 被引量:1
  • 10Kesteren C, Twelves C, Bowman A, et al. Clinical pharmacology of the novel marine-derived anticancer agent Ecteinascidin 743 administered as a 1- and 3-h infusion in a phase I study[J]. Anticuncer Drugs ,2002 , 13(4) : 381. 被引量:1

共引文献7

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部